Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Mangalam Drugs & Organics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	475	439	1,175	1,466	1,549	1,628
Market Cap Growth	-61.05%	-62.63%	-19.89%	-5.31%	-4.86%	3.47%
Enterprise Value	1,595	1,420	2,108	2,355	2,372	2,383
Last Close Price	29.41	27.15	74.30	92.10	98.00	102.40
PE Ratio	-	-	17.48	-	121.95	8.28
PS Ratio	0.20	0.19	0.37	0.40	0.42	0.36
PB Ratio	0.46	0.43	0.79	1.08	1.02	1.08
P/TBV Ratio	0.68	0.63	0.82	1.19	1.16	1.19
P/FCF Ratio	-	-	5.25	-	13.34	-
P/OCF Ratio	11.36	10.51	2.76	37.48	3.92	6.33
EV/Sales Ratio	0.68	0.61	0.66	0.64	0.64	0.53
EV/EBITDA Ratio	-	-	6.39	30.65	9.84	5.03
EV/EBIT Ratio	-	-	10.78	84.17	16.21	6.14
EV/FCF Ratio	-20.65	-	9.41	-	20.43	-
Debt / Equity Ratio	1.09	1.09	0.65	0.79	0.58	0.58
Debt / EBITDA Ratio	-	-	2.74	11.42	3.53	1.81
Debt / FCF Ratio	-	-	4.30	-	7.63	-
Net Debt / Equity Ratio	1.09	1.09	0.63	0.78	0.56	0.57
Net Debt / EBITDA Ratio	-7.92	-7.92	2.84	13.77	3.56	1.82
Net Debt / FCF Ratio	-14.50	-14.50	4.18	-13.36	7.40	-43.85
Asset Turnover	0.68	0.68	0.91	1.06	1.08	1.52
Inventory Turnover	1.30	1.30	1.30	1.89	1.99	3.53
Quick Ratio	0.21	0.21	0.22	0.18	0.30	0.37
Current Ratio	0.79	0.79	1.04	1.07	1.25	1.42
Return on Equity (ROE)	-35.23%	-35.23%	4.72%	-6.30%	0.84%	13.97%
Return on Assets (ROA)	-5.94%	-5.94%	3.49%	0.50%	2.66%	8.19%
Return on Invested Capital (ROIC)	-14.69%	-14.14%	8.08%	1.17%	3.54%	12.60%
Return on Capital Employed (ROCE)	-27.30%	-27.30%	11.20%	1.60%	7.50%	19.60%
Earnings Yield	-93.53%	-101.12%	5.72%	-6.19%	0.82%	12.07%
FCF Yield	-16.27%	-17.59%	19.06%	-5.40%	7.50%	-1.20%
Buyback Yield / Dilution	-0.00%	-0.00%	-	-	-	-
Total Shareholder Return	-0.00%	-0.00%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.